Diabetes & aspirin
This article was originally published in The Tan Sheet
Executive Summary
Nearly half of American adults with diabetes are not using aspirin therapy to reduce their risk of recurrent heart attack or stroke, nor have they discussed such therapy with their physician, according to a survey released Nov. 21 by the American College of Preventive Medicine. Results were drawn from an eight-day online survey of 1,299 consumers over the age of 40 that was conducted in October 2004. The survey was conducted by Harris Interactive and was supported by an unrestricted educational grant from Bayer Healthcare. Approximately 15% of the respondents indicated they have diabetes, which places them at higher risk of cardiovascular-related events, according to the American Diabetes Association. While nearly half of the group with diabetes considered themselves "extremely knowledgeable" about aspirin, only 25% agreed that "the benefits of aspirin therapy strongly outweigh the risks"...